M52K (p.Met52Lys) variant of DRD3 (Dopamine receptor D3)

M52K (p.Met52Lys) in DRD3 (Dopamine receptor D3) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes structural context.

M52K (p.Met52Lys) variant details